This report was recently updated on November 15 2024 with the latest and most recent
market numbers
Global CRISPR & Cas Genes Market Size, Trends & Analysis - Forecasts to 2028 By Application Type (Biomedical and Agricultural), By End User Type (Pharmaceutical Companies, Academic Institutes, and CROs), By Service Type (Cell Line Engineering, gRNA Design, Microbial Gene Editing, and DNA Synthesis), By Product Type (Kits & Enzymes, Libraries, Design Tool, Antibodies, and Others), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
The global CRISPR & cas genes market is expected to grow at a CAGR of 15.5% from 2023 to 2028. The CRISPR and cas genes market is witnessing significant growth due to revolutionary applications of CRISPR and cas genes in various fields. In cancer treatment, CRISPR technology has enhanced the therapeutic efficacy of modified T-cells and the development of CAR-T cells, promising improved outcomes for malignancies. Caribou Biosciences' chRDNA genome-editing technology has shown great potential in boosting genome editing specificity and efficacy for allogeneic cell therapies. Beyond healthcare, gene editing techniques have gained traction in agriculture, enabling innovative breeding strategies to enhance produce quality and environmental and pest resistance. These advances are expected to drive market growth as demand increases for applying CRISPR and Cas genes in biomedical and biotechnological industries.
Due to its diverse industry applications, CRISPR and cas genes technology is witnessing increased demand. In healthcare, it shows immense promise for revolutionizing cancer treatment by enhancing T-cell modification and CAR-T cell therapies. Caribou Biosciences' chRDNA genome-editing technology boosts allogeneic cell therapies, further driving market growth. CRISPR and Cas genes enable innovative breeding strategies in agriculture, improving produce quality, environmental resistance, and pest resistance. The rising demand for gene editing techniques in karyotyping, neonatal screening, and diagnostics contributes to market expansion. Substantial investments and research efforts have accelerated innovation and broadened the understanding of CRISPR's potential, attracting more stakeholders. Supportive regulatory environments, particularly in the medical field, encourage research and commercialization of CRISPR and Cas genes. The convergence of breakthroughs in healthcare, biotechnology, and agriculture, along with regulatory support, fuels the market growth, with even more potential for expansion in the future.
CRISPR and Cas genes market players have numerous opportunities to capitalize on the growing demand and potential applications of the technology. These include biomedical advancements, agricultural innovations, diagnostic and research tools, therapeutic development, therapeutic delivery systems, and industrial applications. The companies can focus on personalized medicine, gene therapies, regenerative medicine, enhancing crop traits, increasing yields, and improving food quality and sustainability. Additionally, market players can develop efficient and safe delivery mechanisms for CRISPR components into target cells, enhancing therapeutic applications and minimizing off-target effects. By strategically focusing on these opportunities, companies can leverage the immense potential of CRISPR and Cas genes technology to drive innovation, expand market presence, and positively impact various industries and human well-being.
Based on the service type, the market is segmented into cell line engineering, gRNA design, microbial gene editing, and DNA synthesis. The cell line engineering segment is expected to be the largest segment during the forecast period. This is due to its broad applications in various industries, including healthcare, agriculture, and biotechnology, leveraging CRISPR and Cas genes technology to modify cell lines for research, therapeutic development, and agricultural advancements.
Based on the application type, the market is segmented into biomedical and agricultural. The biomedical will be the largest segment during the forecast period. This is because of CRISPR's potential in revolutionizing personalized medicine, gene therapies, and regenerative medicine, offering effective solutions for various diseases and disorders, driving its prominence in the market.
Based on the product type, the market is segmented into kits & enzymes, libraries, design tool, antibodies, and others. The kits & enzymes segment will be the largest segment during the forecast period. This is due to its vital role in simplifying and enabling CRISPR technology adoption. These kits offer ready-to-use components, streamlining the gene editing process for researchers, while enzymes are essential tools for precise and efficient genome editing, driving their high demand in the market.
Based on the end user type, the market is segmented into pharmaceutical companies, academic institutes and CROs. The pharmaceutical companies’ segment is anticipated to be the largest segment during the forecast period. This is because of the immense potential of CRISPR and Cas genes technology in revolutionizing medical treatments, including cancer therapies, personalized medicine, and gene therapies, leading to increased investment and research from pharmaceutical companies to capitalize on these opportunities.
North America is analyzed to be the largest region in the global CRISPR & Cas genes market in the forecast period. The region’s biotechnology and healthcare infrastructure supports extensive gene editing research and development. Government and private sector investments have boosted CRISPR applications, fostering innovation. The regulatory environment is favourable, with clear guidelines for gene-editing technologies in research and clinical settings. Collaborations between academic institutions, research centres, and industry players accelerate technology adoption and commercialization. North America's large pharmaceutical and agricultural industries drive demand for CRISPR-based therapies, contributing to its position as the largest region in the global CRISPR and Cas genes market.
Asia Pacific is expected to be the fastest growing region across the global CRISPR & Cas genes market. The APAC region is witnessing significant investments in biotechnology and healthcare research, promoting gene editing technologies. The increasing prevalence of cancer and genetic disorders has led to a demand for innovative therapies like CRISPR-based treatments. The agricultural sector faces challenges like population growth and food security, promoting CRISPR adoption in crop improvement programs. The supportive regulatory environment in some countries has facilitated the development and commercialization of CRISPR-based products. The region's expanding economies and focus on research make it an attractive market for players to capitalize on CRISPR and Cas genes technology opportunities.
The key players operating in the market are AstraZeneca plc, Caribou Biosciences Inc., GenScript, Lonza, F. Hoffmann-La Roche Ltd., Danaher, Merck KGaA, Takara Bio Inc., Thermo Fisher Scientific, and Mammoth Biosciences among others.
Please note: This is not an exhaustive list of companies profiled in the report.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
2.4 Data Metrics
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
4 GLOBAL CRISPR & CAS GENES MARKET, BY PRODUCT TYPE
4.2 CRISPR & Cas Genes Market: Product Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4.1 Kits & Enzymes Market Estimates and Forecast, 2020-2028 (USD Billion)
4.5.1 Libraries Market Estimates And Forecast, 2020-2028 (USD Billion)
4.6.1 Design Tool Market Estimates and Forecast, 2020-2028 (USD Billion)
4.7.1 Antibodies Market Estimates and Forecast, 2020-2028 (USD Billion)
4.8.1 Other Products Market Estimates and Forecast, 2020-2028 (USD Billion)
5 GLOBAL CRISPR & CAS GENES MARKET, BY END USER TYPE
5.2 CRISPR & Cas Genes Market: End User Type Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4.1 Pharmaceutical Companies Market Estimates and Forecast, 2020-2028 (USD Billion)
5.5.1 Academic Institutes Market Estimates and Forecast, 2020-2028 (USD Billion)
5.6.1 CROs Market Estimates and Forecast, 2020-2028 (USD Billion)
6 GLOBAL CRISPR & CAS GENES MARKET, BY APPLICATION TYPE
6.2 CRISPR & Cas Genes Market: Application Type Scope Key Takeaways
6.3 Revenue Growth Analysis, 2022 & 2028
6.4.1 Biomedical Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.1 Agricultural Market Estimates and Forecast, 2020-2028 (USD Billion)
7 GLOBAL CRISPR & CAS GENES MARKET, BY SERVICE TYPE
7.2 CRISPR & Cas Genes Market: Service Type Scope Key Takeaways
7.3 Revenue Growth Analysis, 2022 & 2028
7.4.1 Cell Line Engineering Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.1 GRNA Design Market Estimates and Forecast, 2020-2028 (USD Billion)
7.6.1 Microbial Gene Editing Market Estimates and Forecast, 2020-2028 (USD Billion)
7.7.1 DNA Synthesis Market Estimates and Forecast, 2020-2028 (USD Billion)
8 GLOBAL CRISPR & CAS GENES MARKET, BY REGION
8.2 North America CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.2.5.1 U.S. CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.2.5.2 Canada CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.2.5.3 Mexico CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3 Europe CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.1 Germany CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.2 U.K. Presered Flowers Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.3 France CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.4 Italy CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.5 Spain CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.6 Netherlands CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.7 Rest of Europe CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4 Asia Pacific CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.1 China CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.2 Japan CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.3 India CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.4 South Korea CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.5 Singapore CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.6 Malaysia CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.7 Thailand CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.8 Indonesia CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.9 Vietnam CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.10 Taiwan CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.10.3 By Application Type
8.4.5.11.3 By Application Type
8.5 Middle East and Africa CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.5.1 Saudi Arabia CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.5.2 U.A.E. CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.5.3 Israel CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.5.4 South Africa CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.5.1 Brazil CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.5.2 Argentina CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.5.3 Chile CRISPR & Cas Genes Market Estimates and Forecast, 2020-2028 (USD Billion)
9.1 Company Market Share Analysis
9.2 Four Quadrant Positioning Matrix
9.4.1.1 Business Description & Financial Analysis
9.4.1.3 Products & Services Offered
9.4.1.4 Strategic Alliances between Business Partners
9.4.2 Thermo Fisher Scientific
9.4.2.1 Business Description & Financial Analysis
9.4.2.3 Products & Services Offered
9.4.2.4 Strategic Alliances between Business Partners
9.4.3 F. Hoffmann-La Roche Ltd.
9.4.3.1 Business Description & Financial Analysis
9.4.3.3 Products & Services Offered
9.4.3.4 Strategic Alliances between Business Partners
9.4.4 Caribou Biosciences Inc.
9.4.4.1 Business Description & Financial Analysis
9.4.4.3 Products & Services Offered
9.4.4.4 Strategic Alliances between Business Partners
9.4.5.1 Business Description & Financial Analysis
9.4.5.3 Products & Services Offered
9.4.5.4 Strategic Alliances between Business Partners
9.4.6.1 Business Description & Financial Analysis
9.4.6.3 Products & Services Offered
9.4.6.4 Strategic Alliances between Business Partners
9.4.7.1 Business Description & Financial Analysis
9.4.7.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.8.1 Business Description & Financial Analysis
9.4.8.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.9.1 Business Description & Financial Analysis
9.4.9.3 Products & Services Offered
9.4.9.4 Strategic Alliances between Business Partners
9.4.10.1 Business Description & Financial Analysis
9.4.10.3 Products & Services Offered
9.4.10.4 Strategic Alliances between Business Partners
10.1.2 Market Scope & Segmentation
10.2.1.2 GMEs Internal Data Repository
10.2.1.3 Secondary Resources & Third Party Perspectives
10.2.1.4 Company Information Sources
10.2.2.1 Various Types of Respondents for Primary Interviews
10.2.2.2 Number of Interviews Conducted throughout the Research Process
10.2.2.4 Discussion Guide for Primary Participants
10.2.3.1 Expert Panels Across 30+ Industry
10.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
10.3.1.1 Macro-Economic Indicators Considered
10.3.1.2 Micro-Economic Indicators Considered
10.3.2.1 Company Share Analysis Approach
10.3.2.2 Estimation of Potential Product Sales
10.4.2 Time Series, Cross Sectional & Panel Data Analysis
10.5.1 Inhouse AI Based Real Time Analytics Tool
10.5.2 Output From Desk & Primary Research
10.6 Research Assumptions & Limitations
LIST OF TABLES
1 Global CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
2 Kits & Enzymes Market, By Region, 2020-2028 (USD Billion)
3 LIBRARIES Market, By Region, 2020-2028 (USD Billion)
4 Design Tool Market, By Region, 2020-2028 (USD Billion)
5 Antibodies Market, By Region, 2020-2028 (USD Billion)
6 Other Products Market, By Region, 2020-2028 (USD Billion)
7 Global CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
8 Pharmaceutical Companies Market, By Region, 2020-2028 (USD Billion)
9 ACADEMIC INSTITUTES Market, By Region, 2020-2028 (USD Billion)
10 CROs Market, By Region, 2020-2028 (USD Billion)
11 Global CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
12 Biomedical Market, By Region, 2020-2028 (USD Billion)
13 Agricultural Market, By Region, 2020-2028 (USD Billion)
14 Global CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
15 Cell Line Engineering Market, By Region, 2020-2028 (USD Billion)
16 GRNA Design Market, By Region, 2020-2028 (USD Billion)
17 Microbial Gene Editing Market, By Region, 2020-2028 (USD Billion)
18 DNA Synthesis Market, By Region, 2020-2028 (USD Billion)
19 Regional Analysis, 2020-2028 (USD Billion)
20 North America CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
21 North America CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
22 North America CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
23 North America CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
24 North America CRISPR & Cas Genes Market, By Country, 2020-2028 (USD Billion)
25 U.S CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
26 U.S CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
27 U.S CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
28 U.S CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
29 Canada CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
30 Canada CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
31 Canada CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
32 CANADA CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
33 Mexico CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
34 Mexico CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
35 Mexico CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
36 mexico CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
37 Europe CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
38 Europe CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
39 Europe CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
40 europe CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
41 Germany CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
42 Germany CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
43 Germany CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
44 germany CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
45 UK CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
46 UK CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
47 UK CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
48 U.k CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
49 France CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
50 France CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
51 France CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
52 france CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
53 Italy CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
54 Italy CRISPR & Cas Genes Market, By T End User Type Type, 2020-2028 (USD Billion)
55 Italy CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
56 italy CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
57 Spain CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
58 Spain CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
59 Spain CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
60 spain CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
61 Rest Of Europe CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
62 Rest Of Europe CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
63 Rest of Europe CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
64 REST OF EUROPE CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
65 Asia Pacific CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
66 Asia Pacific CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
67 Asia Pacific CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
68 asia CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
69 Asia Pacific CRISPR & Cas Genes Market, By Country, 2020-2028 (USD Billion)
70 China CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
71 China CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
72 China CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
73 china CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
74 India CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
75 India CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
76 India CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
77 india CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
78 Japan CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
79 Japan CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
80 Japan CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
81 japan CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
82 South Korea CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
83 South Korea CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
84 South Korea CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
85 south korea CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
86 Middle East and Africa CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
87 Middle East and Africa CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
88 Middle East and Africa CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
89 MIDDLE EAST AND AFRICA CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
90 Middle East and Africa CRISPR & Cas Genes Market, By Country, 2020-2028 (USD Billion)
91 Saudi Arabia CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
92 Saudi Arabia CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
93 Saudi Arabia CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
94 saudi arabia CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
95 UAE CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
96 UAE CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
97 UAE CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
98 uae CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
99 Central & South America CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
100 Central & South America CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
101 Central & South America CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
102 CENTRAL & SOUTH AMERICA CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
103 Central & South America CRISPR & Cas Genes Market, By Country, 2020-2028 (USD Billion)
104 Brazil CRISPR & Cas Genes Market, By Product Type, 2020-2028 (USD Billion)
105 Brazil CRISPR & Cas Genes Market, By End User Type, 2020-2028 (USD Billion)
106 Brazil CRISPR & Cas Genes Market, By Application Type, 2020-2028 (USD Billion)
107 brazil CRISPR & Cas Genes Market, By Service Type, 2020-2028 (USD Billion)
108 AstraZeneca plc.: Products & Services Offering
109 Thermo Fisher Scientific: Products & Services Offering
110 F. Hoffmann-La Roche Ltd.: Products & Services Offering
111 Caribou Biosciences Inc.: Products & Services Offering
112 GenScript: Products & Services Offering
113 LONZA: Products & Services Offering
114 Merck KGaA: Products & Services Offering
115 Takara Bio Inc.: Products & Services Offering
116 Mammoth Biosciences, Inc: Products & Services Offering
117 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global CRISPR & Cas Genes Market Overview
2 Global CRISPR & Cas Genes Market Value From 2020-2028 (USD Billion)
3 Global CRISPR & Cas Genes Market Share, By Product Type (2022)
4 Global CRISPR & Cas Genes Market Share, By End User Type (2022)
5 Global CRISPR & Cas Genes Market Share, By Application Type (2022)
6 Global CRISPR & Cas Genes Market Share, By Service Type (2022)
7 Global CRISPR & Cas Genes Market, By Region (Asia Pacific Market)
8 Technological Trends In Global CRISPR & Cas Genes Market
9 Four Quadrant Competitor Positioning Matrix
10 Impact Of Macro & Micro Indicators On The Market
11 Impact Of Key Drivers On The Global CRISPR & Cas Genes Market
12 Impact Of Challenges On The Global CRISPR & Cas Genes Market
13 Porter’s Five Forces Analysis
14 Global CRISPR & Cas Genes Market: By Product Type Scope Key Takeaways
15 Global CRISPR & Cas Genes Market, By Product Type Segment: Revenue Growth Analysis
16 Kits & Enzymes Market, By Region, 2020-2028 (USD Billion)
17 Libraries Market, By Region, 2020-2028 (USD Billion)
18 Design Tool Market, By Region, 2020-2028 (USD Billion)
19 Antibodies Market, By Region, 2020-2028 (USD Billion)
20 Other Products Market, By Region, 2020-2028 (USD Billion)
21 Global CRISPR & Cas Genes Market: By End User Type Scope Key Takeaways
22 Global CRISPR & Cas Genes Market, By End User Type Segment: Revenue Growth Analysis
23 Pharmaceutical Companies Market, By Region, 2020-2028 (USD Billion)
24 Academic Institutes Market, By Region, 2020-2028 (USD Billion)
25 CROs Market, By Region, 2020-2028 (USD Billion)
26 Global CRISPR & Cas Genes Market: By Application Type Scope Key Takeaways
27 Global CRISPR & Cas Genes Market, By Application Type Segment: Revenue Growth Analysis
28 Biomedical Market, By Region, 2020-2028 (USD Billion)
29 Agricultural Market, By Region, 2020-2028 (USD Billion)
30 Global CRISPR & Cas Genes Market: By Service Type Scope Key Takeaways
31 Global CRISPR & Cas Genes Market, By Service Type Segment: Revenue Growth Analysis
32 Cell Line Engineering Market, By Region, 2020-2028 (USD Billion)
33 GRNA Design Market, By Region, 2020-2028 (USD Billion)
34 Microbial Gene Editing Market, By Region, 2020-2028 (USD Billion)
35 DNA Synthesis Market, By Region, 2020-2028 (USD Billion)
36 Regional Segment: Revenue Growth Analysis
37 Global CRISPR & Cas Genes Market: Regional Analysis
38 North America CRISPR & Cas Genes Market Overview
39 North America CRISPR & Cas Genes Market, By Product Type
40 North America CRISPR & Cas Genes Market, By End User Type
41 North America CRISPR & Cas Genes Market, By Application Type
42 North America CRISPR & Cas Genes Market, By Service Type
43 North America CRISPR & Cas Genes Market, By Country
44 U.S. CRISPR & Cas Genes Market, By Product Type
45 U.S. CRISPR & Cas Genes Market, By End User Type
46 U.S. CRISPR & Cas Genes Market, By Application Type
47 U.S. CRISPR & Cas Genes Market, By Service Type
48 Canada CRISPR & Cas Genes Market, By Product Type
49 Canada CRISPR & Cas Genes Market, By End User Type
50 Canada CRISPR & Cas Genes Market, By Application Type
51 Canada CRISPR & Cas Genes Market, By Service Type
52 Mexico CRISPR & Cas Genes Market, By Product Type
53 Mexico CRISPR & Cas Genes Market, By End User Type
54 Mexico CRISPR & Cas Genes Market, By Application Type
55 Mexico CRISPR & Cas Genes Market, By Service Type
56 Four Quadrant Positioning Matrix
57 Company Market Share Analysis
58 AstraZeneca plc.: Company Snapshot
59 AstraZeneca plc.: SWOT Analysis
60 AstraZeneca plc.: Geographic Presence
61 Thermo Fisher Scientific: Company Snapshot
62 Thermo Fisher Scientific: SWOT Analysis
63 Thermo Fisher Scientific: Geographic Presence
64 F. Hoffmann-La Roche Ltd.: Company Snapshot
65 F. Hoffmann-La Roche Ltd.: SWOT Analysis
66 F. Hoffmann-La Roche Ltd.: Geographic Presence
67 Caribou Biosciences Inc.: Company Snapshot
68 Caribou Biosciences Inc.: Swot Analysis
69 Caribou Biosciences Inc.: Geographic Presence
70 GenScript: Company Snapshot
71 GenScript: SWOT Analysis
72 GenScript: Geographic Presence
73 Lonza: Company Snapshot
74 Lonza: SWOT Analysis
75 Lonza: Geographic Presence
76 Merck KGaA: Company Snapshot
77 Merck KGaA: SWOT Analysis
78 Merck KGaA: Geographic Presence
79 Takara Bio Inc.: Company Snapshot
80 Takara Bio Inc.: SWOT Analysis
81 Takara Bio Inc.: Geographic Presence
82 Mammoth Biosciences, Inc.: Company Snapshot
83 Mammoth Biosciences, Inc.: SWOT Analysis
84 Mammoth Biosciences, Inc.: Geographic Presence
85 Other Companies: Company Snapshot
86 Other Companies: SWOT Analysis
87 Other Companies: Geographic Presence
The Global CRISPR & Cas Genes Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the CRISPR & Cas Genes Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
